| Emily Franco Hoffman, CNM/NP | |
|
24850 Se Stark St., Suite 200, Gresham, OR 97030-8320 | |
| (503) 491-9444 | |
| (503) 661-3430 |
| Full Name | Emily Franco Hoffman |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 11 Years |
| Location | 24850 Se Stark St., Gresham, Oregon |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750719902 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 201393471NP-PP (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Silver Spring Health Care Management Inc | 4688661127 | 118 |
News Archive
NovaBay(R) Pharmaceuticals, Inc. (NYSE-Amex: NBY), (http://www.novabaypharma.com), a clinical stage company developing novel anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral and fungal infections, announced today the start of a Phase 2a proof-of-concept study of its lead Aganocide(R) compound NVC-422 in impetigo.
Serono and IVAX Corporation have announced positive results from two clinical trials with a new proprietary oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS).
Catasys, Inc. and Health Alliance Medical Plans today announced a multi-year agreement to offer Catasys' OnTrak Program to Health Alliance members in need in Illinois. OnTrak provides support and guidance to commercial, Medicaid and Medicare Advantage members struggling with both medical and behavioral conditions.
A new review of existing evidence proposes eight hallmarks of environmental exposures that chart the biological pathways through which pollutants contribute to disease: oxidative stress and inflammation, genomic alterations and mutations, epigenetic alterations, mitochondrial dysfunction, endocrine disruption, altered intercellular communication, altered microbiome communities, and impaired nervous system function.
› Verified 1 days ago
| Entity Name | Silver Spring Health Care Management Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245246115 PECOS PAC ID: 4688661127 Enrollment ID: O20070125000408 |
News Archive
NovaBay(R) Pharmaceuticals, Inc. (NYSE-Amex: NBY), (http://www.novabaypharma.com), a clinical stage company developing novel anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral and fungal infections, announced today the start of a Phase 2a proof-of-concept study of its lead Aganocide(R) compound NVC-422 in impetigo.
Serono and IVAX Corporation have announced positive results from two clinical trials with a new proprietary oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS).
Catasys, Inc. and Health Alliance Medical Plans today announced a multi-year agreement to offer Catasys' OnTrak Program to Health Alliance members in need in Illinois. OnTrak provides support and guidance to commercial, Medicaid and Medicare Advantage members struggling with both medical and behavioral conditions.
A new review of existing evidence proposes eight hallmarks of environmental exposures that chart the biological pathways through which pollutants contribute to disease: oxidative stress and inflammation, genomic alterations and mutations, epigenetic alterations, mitochondrial dysfunction, endocrine disruption, altered intercellular communication, altered microbiome communities, and impaired nervous system function.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emily Franco Hoffman, CNM/NP 24850 Se Stark St., Suite 200, Gresham, OR 97030-3399 Ph: (503) 491-9444 | Emily Franco Hoffman, CNM/NP 24850 Se Stark St., Suite 200, Gresham, OR 97030-8320 Ph: (503) 491-9444 |
News Archive
NovaBay(R) Pharmaceuticals, Inc. (NYSE-Amex: NBY), (http://www.novabaypharma.com), a clinical stage company developing novel anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral and fungal infections, announced today the start of a Phase 2a proof-of-concept study of its lead Aganocide(R) compound NVC-422 in impetigo.
Serono and IVAX Corporation have announced positive results from two clinical trials with a new proprietary oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS).
Catasys, Inc. and Health Alliance Medical Plans today announced a multi-year agreement to offer Catasys' OnTrak Program to Health Alliance members in need in Illinois. OnTrak provides support and guidance to commercial, Medicaid and Medicare Advantage members struggling with both medical and behavioral conditions.
A new review of existing evidence proposes eight hallmarks of environmental exposures that chart the biological pathways through which pollutants contribute to disease: oxidative stress and inflammation, genomic alterations and mutations, epigenetic alterations, mitochondrial dysfunction, endocrine disruption, altered intercellular communication, altered microbiome communities, and impaired nervous system function.
› Verified 1 days ago
June Ellen Hobbs, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 24850 Se Stark St, Suite 200, Gresham, OR 97030 Phone: 503-491-9444 Fax: 503-661-3430 | |
Julie Shiprack, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 24850 Se Stark St Ste 200, Gresham, OR 97030 Phone: 503-491-9444 | |
Ms. Kirsten Gwynn, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 24850 Se Stark St Ste 200, Gresham, OR 97030 Phone: 503-491-9444 Fax: 503-661-3430 |